K. Kourtis

Methylation of estrogen receptor β promoter correlates with loss of ER-β expression in mammary carcinoma and is an early indication marker in premalignant lesions

Achim Rody, Uwe Holtrich, Christine Solbach et al. · Endocrine Related Cancer · 2005 · 81 citations · Full text

Breast Oncology, Gynecology, Pathology +16

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response

Achim Rody, Thomas Karn, R. Gätje et al. · The Breast · 2006 · 80 citations

Tumor Response, Breast Oncology, Breast Cancer Patients +11

Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis

R. Gaetje, Uwe Holtrich, Knut Engels et al. · Gynecological Endocrinology · 2007 · 31 citations

Gene Expression Profiles of Breast Cancer Obtained from Core Cut Biopsies Before Neoadjuvant Docetaxel, Adriamycin, and Cyclophoshamide Chemotherapy Correlate with Routine Prognostic Markers and Could Be Used to Identify Predictive Signatures

Achim Rody, Thomas Karn, R. Gätje et al. · Zentralblatt für Gynäkologie · 2006 · 24 citations